BPC-157 for sale from Portal to Wellness — research-grade material in injectable and oral formats, supplied for laboratory use only. BPC-157 (Body Protection Compound-157) is a synthetic 15–amino-acid peptide sequence. All material is sold for research and identification purposes only.
The compound is written variously as BPC-157, BPC157 or BPC 157, and is frequently mis-typed as BCP-157 or BP157. All of these refer to the same 15-residue sequence described below. Portal to Wellness lists it in five presentations, priced and specified on this page.
BPC-157 formats available
| Format | Presentation | Price | |
|---|---|---|---|
| Injectable vial — single compound | 10mg BPC-157 only | $56.00 | View → |
| BPC-157 + TB-500 injectable | 10mg/vial — 5mg BPC-157 + 5mg TB-500, lyophilised | $69.00 | View → |
| BPC-157 oral capsules | 500mcg × 100 capsules | $155.00 | View → |
| BPC-157 + TB-500 oral | 500mcg + 500mcg × 100 capsules | $94.05 | View → |
| GLOW-70 blend | GHK-Cu 50mg + TB-500 10mg + BPC-157 10mg per vial | $112.00 | View → |
Choosing between the injectable and oral formats
The formats differ in presentation and preparation, not in the identity of the sequence.
Injectable vials arrive as lyophilised — freeze-dried — powder in a sealed, stoppered vial. Material in this form must be brought into solution before it can be handled as a liquid, and the vial contents are stated by total mass rather than by concentration, since concentration depends on the diluent volume chosen by the researcher.
Oral capsules arrive pre-filled and require no preparation. Capsule counts and per-capsule mass are stated on each listing.
Single-compound vials contain BPC-157 and nothing else. Where a study design needs one variable isolated, this is the presentation that allows it.
Blends combine BPC-157 with TB-500 in one presentation, and the GLOW-70 vial adds GHK-Cu to that pair. Blends are supplied as a convenience where a design calls for the combination; they cannot be separated back into their components once vialled. Our comparison of the two compounds is here: BPC-157 vs TB-500.
Which presentation suits a given piece of work is a decision for the researcher. We do not advise on study design, and nothing on this page should be read as a recommendation to use this material in any particular way.
Specifications
- Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids)
- Form: Lyophilised powder (injectable formats) or capsule (oral formats)
- Storage: Lyophilised material stored refrigerated, protected from light. See our handling and storage notes.
- Shipping: Orders placed before 2 PM EST ship the same business day, Monday–Friday, in plain unmarked packaging with tracking.
Storage and handling
- Lyophilised vials: refrigerated, in the sealed vial, protected from light. Lyophilised peptide is the more stable of the two states.
- Capsules: cool, dry, out of direct light, in the supplied container.
- In transit: shipped without cold chain. Lyophilised material tolerates ambient temperature for the duration of domestic transit; refrigerate on arrival.
- Handling: avoid repeated freeze–thaw cycles.
Testing status
We are being direct about this rather than implying coverage we do not have.
BPC-157 now has a published Certificate of Analysis from our own testing. We removed our previous COA listings because they were submitted by our supplier and could not be independently verified — details on the Lab Testing & Verification page.
A BPC-157 10mg sample from our own stock (batch PTW-BPC10-2608-001) was tested by Janoshik Analytical (task #239840, analysis conducted 12 Oct 2026): 11.55 mg per vial against a 10 mg label, and 97.035% purity by HPLC; the laboratory tested the sample twice. View and verify the full report on Janoshik’s site.
If you want the current testing status before ordering, ask us and we will tell you plainly.
Two measurements matter on a peptide certificate. HPLC purity separates the sample and reports what proportion of it is the target sequence rather than truncated fragments or process residue. Mass spectrometry identity confirms the molecular weight matches the sequence claimed. A certificate that reports one without the other is incomplete. We explain how to read both, and what the common gaps look like, in how to read a peptide COA.
Research background
BPC-157 is characterised largely in rodent gastrointestinal and soft-tissue models. Direct controlled human data is limited — researchers observed the bulk of reported findings in animal work rather than in people. We keep our summaries of that literature separate from our product pages, with citations:
- BPC-157 research overview
- BPC-157 and TB-500 compared
- BPC-157 and angiogenesis research
- How to read a peptide COA
In July 2026 an FDA advisory committee voted 8–6, with one abstention, to recommend BPC-157 for the 503A bulk drug substances list. That is an advisory recommendation, not an approval, and it does not change the compound’s regulatory status. Our summary of that review is here: the July 2026 FDA peptide review. For an honest account of where the evidence is thin, see recovery peptide evidence gaps.
These are summaries of published preclinical research. They are not claims about what this material does, and nothing on this site should be read as a representation of safety or efficacy in humans.
Ordering
- Where we ship: addresses within the United States only. We do not ship internationally.
- Dallas–Fort Worth: local delivery and local pickup are available at checkout for DFW addresses, with no delivery charge on pickup.
- Dispatch: orders placed before 2 PM EST ship the same business day, Monday to Friday.
- Packaging: plain, unmarked, with tracking on every order.
- Payment: Zelle and cryptocurrency are accepted at checkout.
- Shipping cost: free on orders over $150.
- Volume discounts: applied automatically at $150, $300 and $600.
- Eligibility: purchasers must be 18 or older. We supply laboratories and independent researchers.
Browse all recovery & repair compounds →
Frequently asked questions
What does “research use only” mean on this page?
It means the material is supplied for laboratory research and identification work, and is not supplied for human or veterinary use. It is not a medicine, it is not approved for any human application, and we make no claim that it is safe or effective in people. This is a description of what the material is sold for, not a formality.
Do you ship outside the United States?
No. We ship to United States addresses only. Importing peptides into most other jurisdictions requires licences held by the importer rather than the seller, and we are not set up for it.
What is the difference between the single-compound vial and the BPC-157 + TB-500 blend?
The single-compound vial contains 10mg of BPC-157 and nothing else. The blend vial contains 10mg total, split 5mg BPC-157 and 5mg TB-500. The blend cannot be separated into its components after vialling, so a design that needs BPC-157 isolated needs the single-compound vial.
Why is there no Certificate of Analysis for BPC-157 right now?
Because we withdrew the previous ones. They were supplied by our vendor rather than commissioned by us, and we could not independently verify them. Samples pulled from our own stock are in the first round of our own testing programme, and results will be published here with batch numbers and full reports when they land. Until then we would rather say so than publish a certificate we cannot stand behind.
Is the capsule the same material as the vial?
The sequence is the same. The presentation, the stated mass per unit and the preparation required all differ, and those differences are stated on each listing.
How quickly will my order ship?
Same business day for orders placed before 2 PM EST, Monday to Friday. Tracking is issued on despatch. Items marked as restocking on the table above are the exception; their listing states current availability.
Do I need to be a registered laboratory to order?
No. We supply both laboratories and independent researchers. Purchasers must be 18 or older, and the terms of sale — research and identification use only — apply to every order regardless of who places it.
What is BPC-157’s current regulatory status?
It is not an approved drug. In July 2026 an FDA advisory committee voted 8–6, with one abstention, to recommend it for the 503A bulk drug substances list; that is an advisory recommendation and it did not change the compound’s status. Our account of that meeting is here.
All products sold on this website are intended for research and identification purposes only. They are not intended for human dosing, injection, or ingestion, and are not for veterinary use. Must be 18 or older to purchase. This page is provided for informational and educational purposes. No therapeutic claims are made or implied.
Research References
- Pentadecapeptide BPC 157 and its healing properties: A review Sikiric P et al. Curr Pharm Des. 2018.
- Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease Sikiric P et al. Curr Pharm Des. 2011.
- BPC 157 counteracts corticoid-impairment of muscle, tendon and bone healing Chang CH et al. J Orthop Res. 2014.
All compounds sold by Portal to Wellness are intended for research purposes only. Citations are provided for educational context.